152 related articles for article (PubMed ID: 19896340)
1. Kodamaea ohmeri fungaemia successfully treated with caspofungin.
Chiu CH; Wang YC; Shang ST; Chang FY
Int J Antimicrob Agents; 2010 Jan; 35(1):98-9. PubMed ID: 19896340
[No Abstract] [Full Text] [Related]
2. A case report of fungemia due to Kodamaea ohmeri.
Diallo K; Lefevre B; Cadelis G; Gallois JC; Gandon F; Nicolas M; Hoen B
BMC Infect Dis; 2019 Jul; 19(1):570. PubMed ID: 31262263
[TBL] [Abstract][Full Text] [Related]
3. Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature.
Shaaban H; Choo HF; Boghossian J; Perez G
Mycopathologia; 2010 Oct; 170(4):223-8. PubMed ID: 20449770
[TBL] [Abstract][Full Text] [Related]
4. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Shang ST; Lin JC; Ho SJ; Yang YS; Chang FY; Wang NC
J Microbiol Immunol Infect; 2010 Jun; 43(3):200-6. PubMed ID: 21291847
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre.
Chakrabarti A; Rudramurthy SM; Kale P; Hariprasath P; Dhaliwal M; Singhi S; Rao KL
Clin Microbiol Infect; 2014 Feb; 20(2):O83-9. PubMed ID: 24004250
[TBL] [Abstract][Full Text] [Related]
6. Catheter-related bloodstream infection caused by Kodamaea ohmeri: A case report and literature review.
Kanno Y; Wakabayashi Y; Ikeda M; Tatsuno K; Misawa Y; Sato T; Yanagimoto S; Okugawa S; Moriya K; Yotsuyanagi H
J Infect Chemother; 2017 Jun; 23(6):410-414. PubMed ID: 28188094
[TBL] [Abstract][Full Text] [Related]
7. Invasive infection due to Saprochaete capitata in a young patient with hematological malignancies.
Parahym AM; Rolim Neto PJ; da Silva CM; Domingos Ide F; Gonçalves SS; Leite EP; de Morais VL; Macêdo DP; de Lima Neto RG; Neves RP
Braz J Microbiol; 2015 Jun; 46(2):527-30. PubMed ID: 26273269
[TBL] [Abstract][Full Text] [Related]
8. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin.
Lolis N; Veldekis D; Moraitou H; Kanavaki S; Velegraki A; Triandafyllidis C; Tasioudis C; Pefanis A; Pneumatikos I
Crit Care; 2008; 12(2):414. PubMed ID: 18423057
[TBL] [Abstract][Full Text] [Related]
9. Saprochaete capitata as an emerging fungus among patients with haematological malignencies.
Ulu-Kilic A; Atalay MA; Metan G; Cevahir F; Koç N; Eser B; Çetin M; Kaynar L; Alp E
Mycoses; 2015 Aug; 58(8):491-7. PubMed ID: 26155743
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Fanci R
J Chemother; 2009 Feb; 21(1):105-7. PubMed ID: 19297283
[No Abstract] [Full Text] [Related]
11. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
12. Kodamaea ohmeri as an emerging pathogen: a case report and review of the literature.
Al-Sweih N; Khan ZU; Ahmad S; Devarajan L; Khan S; Joseph L; Chandy R
Med Mycol; 2011 Oct; 49(7):766-70. PubMed ID: 21438792
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study.
Sipsas NV; Lewis RE; Raad II; Kontoyiannis DP
Int J Antimicrob Agents; 2009 Jul; 34(1):95-8. PubMed ID: 19251404
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient.
Tascini C; Urbani L; Doria R; Catalano G; Leonildi A; Filipponi F; Menichetti F
J Chemother; 2009 Apr; 21(2):236-8. PubMed ID: 19423484
[No Abstract] [Full Text] [Related]
15. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
[No Abstract] [Full Text] [Related]
16. Caspofungin for the treatment of candidaemia in patients with haematological malignancies.
Pagano L; Fianchi L; Fanci R; Candoni A; Caira M; Posteraro B; Morselli M; Valentini CG; Farina G; Mitra ME; Offidani M; Sanguinetti M; Tosti ME; Nosari A; Leone G; Viale P
Clin Microbiol Infect; 2010 Mar; 16(3):298-301. PubMed ID: 19549221
[TBL] [Abstract][Full Text] [Related]
17. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica.
Belet N; Ciftçi E; Ince E; Dalgiç N; Oncel S; Güriz H; Yagmurlu A; Dindar H; Doğru U
Scand J Infect Dis; 2006; 38(6-7):559-62. PubMed ID: 16798714
[TBL] [Abstract][Full Text] [Related]
19. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
Hakki M; Staab JF; Marr KA
Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
[TBL] [Abstract][Full Text] [Related]
20. Oral candidiasis caused by Kodamaea ohmeri in a HIV patient in Chennai, India.
Menon T; Herrera M; Periasamy S; Palanivelu V; Sikhamani R; Wickes B
Mycoses; 2010 Sep; 53(5):458-9. PubMed ID: 19531098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
